Gapping down
In reaction to earnings/guidance:
- AAP -25.5%, AMBA -18.3%, HPE -8.4%, SPWH -7.8%, FRO -6%, HPQ -5.9%, UHAL -3.2%, CPRI -1.5%
Other news:
- BLTE -37.2% (prices offering of ADSs and warrants)
- ASLE -10.1% (prices secondary offering of 4.0 mln shares of common stock by selling shareholders)
- PEPG -9.7% (clinical hold on IND application of PGN-EDODM1)
- HRZN -8.8% (prices offering of 3.25 mln shares of common stock at $12.50 per share)
- LTRX -8.6% (CEO to step down)
- PUK -4.3% (CFO resigns; appoints Ben Bulmer as CFO)
- EGO -3.8% (announces C$81.5 mln strategic investment by EBRD and concurrent C$135 mln bought deal financing)
- COIN -2.9% (SEC settles with former product manager and his brother on insider trading charges)
- MERC -1.7% (receives court approval to acquire Structurlam Mass Timber assets)
- KODK -1.6% (acquires Graphic Systems Services)
- BMBL -1.2% (president to resign)
- FRPT -1% (responds to JANA Partners' letter)
Analyst comments:
- PDCE -1.7% (downgraded to Neutral from Buy at Seaport Research Partners)
Gapping up
In reaction to earnings/guidance:
- BOX +0.5%
Other news:
- LL +20.5% (F9 Investments prepared to consider an offer of $5.76/sh for LL)
- CCO +3.9% (closes sale of Italy business to JCDecaux SE (JCDXF) for approx. $16.2 mln (EUR15.1 mln))
- TWLO +3.7% (will lose supervoting protection next month; also co has been meeting with activist according to TheInformation)
- CAE +3% (awarded $455 mln subcontract for US Army Flight School)
- ANIK +2.1% (completes enrollment in Hyalofast phase 3 study)
- NAAS +2.1% (announces $21 million of registered direct offering to certain investors)
- IGMS +1.9% (announces FDA clearance to begin clinical studies of imvotamab in lupus and rheumatoid arthritis)
- SMTC +1.2% (names new CEO)
- SNY +1.1% (reports Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis)
Analyst comments:
- CAR +4.1% (upgraded to Buy from Hold at Deutsche Bank)
- QTWO +2.9% (upgraded to Buy from Neutral at BTIG Research)
All,
New rights issue in Sweden. Very small for SEK 450m or €38m.
Note that the company is issuing A and B shares so 2 spreads but the one-pager below is using the most liquid B shares.
Ticker of the A shares is STARA SS and right is STARTRA SS.
Was ex on May 29th and start trading tomorrow.
Statement on AI Risk
AI experts and public figures express their concern about AI risk.
Early premarket gappers
- Gapping up:
- LL +21.7%, CCO +5.5%, CPRI +4.4%, TWLO +3.5%, CAE +3.1%, BOX +2.5%, ANIK +2.1%, NAAS +2.1%, MRTX +1.1%, SNY +1.1%, RC +0.9%, GLDD +0.6%, MCRB +0.6%, UCBI +0.6%
- Gapping down:
- BLTE -37.1%, AAP -24.9%, AMBA -17.7%, PEPG -16.3%, ASLE -9.7%, HRZN -8.1%, HPE -7.9%, SPWH -7.8%, LTRX -7.6%, FRO -5.7%, EGO -5.2%, HPQ -4.8%, PUK -4%, UHAL -3.2%, COIN -2.2%, MERC -1.7%, FRPT -1%, KODK -0.8%, BMBL -0.8%
>>> Up
* Austriacard Raised to Buy at Raiffeisen Bank; PT 14.50 euros
* Austriacard Raised to Buy at Raiffeisen Bank; PT 14.50 euros
* BW Epic Kosan Ltd Raised to Buy at Norne Securities (+)
* Chevron Raised to Neutral at JPMorgan; PT $170
* J D Wetherspoon Raised to Buy at HSBC; PT 940 pence
* Mediobanca Raised to Add at AlphaValue/Baader
* Mitchells & Butlers Raised to Buy at HSBC; PT 300 pence
>>> Down
* 3i Cut to Add at Numis; PT 2,285 pence
* Ambarella Cut to Sector Weight at KeyBanc
* Datalex Cut to Neutral at Davy (+)
* DWF Group Cut to Sell at Liberum; PT 50 pence
* DWF Group Cut to Sell at Liberum; PT 50 pence
* Enefit Green Cut to Neutral at Citi; PT 4.90 euros
* Inmobiliaria Colonial Cut to Reduce at AlphaValue/Baader
* Nokian Renkaat Cut to Add at AlphaValue/Baader
* Norrhydro Group Cut to Reduce at Inderes; PT 3.20 euros
>>> Initiation
* Bilia Rated New Buy at DNB Markets; PT 130 kronor
>>> Initiation
* Bilia Rated New Buy at DNB Markets; PT 130 kronor
* BNP Paribas Reinstated Neutral at Goldman; PT 76 euros
* Dowlais Rated New Underperform at BNPP Exane; PT 120 pence
* Inventiva SACA ADRs Rated New Buy at Roth MKM; PT $11
* MorphoSys Rated New Buy at UBS; PT 47 euros
* Nice Ltd ADRs Rated New Buy at Mizuho Securities; PT $244
* Ocado Rated New Neutral at Davy; PT 400 pence (+)
* Recordati Rated New Sector Perform at RBC; PT 43.50 euros
* Solid State Rated New Buy at Cenkos Securities (+)
* Vossloh Rated New Buy at Quirin Privatbank AG; PT 51.37 euros (+)
>>> Call
>>> Call
* BT, Hellenic Telecom Are Top Picks at Citi Into Second Quarter
* Chevron Loses Only Sell as JPMorgan Says Premium Has Narrowed
* Femsa Sale of Heineken Shares Removes Overhang Risk: Jefferies (+)
* Recordati Sector Perform at RBC, Premium Reflects Growth Outlook
* Recordati Sector Perform at RBC, Premium Reflects Growth Outlook
* Wartsila Gets Upside Catalyst Watch at Citi on Services Business
- UCB (UNC TH) +0.3%
- Sanofi (SNW TH) +0.2%
- Sanofi’s MS Drug Frexalimab Meets Main Goal in Phase 2 Trial
- Glencore (8GC TH) -1.4%
- Aixtron (AIXA TH) -1.5%
- Carl Zeiss Meditec (AFX TH) -1.5%
- Bechtle (BC8 TH) -1.7%
- Infineon (IFX TH) -1.9%
- Air France-KLM (AFR TH) -1.9%
- BP (BPE5 TH) -2.9%
- Thyssenkrupp (TKA TH) -3%
- Prosus (1TY TH) -3.2%
- Heineken (HNK1 TH) -3.7%
- Heineken Share Offering by Femsa Prices at €92.75/Share